Patient-, Provider-, and Area-Level Factors Associated with Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis in North Carolina
Individuals with non-viral cirrhosis etiologies, Medicare insurance, decompensated cirrhosis, and gastroenterology care in the year before the index date were more likely to receive an HCC surveillance exam in the 2 years after their cirrhosis diagnosis than their counterparts. Findings from this study may serve as a benchmark to measure state-level progress in increasing HCC surveillance and help identify subgroups to target for future interventions.
Authors
- Louise M. Henderson (ORCID: https://orcid.org/0000-0001-8356-9267)
- Christine D. Hsu (ORCID: https://orcid.org/0000-0002-8200-5133)
- Andrew F. Olshan (ORCID: https://orcid.org/0000-0001-9115-5128)
- C D Baggett
- Stephanie B. Wheeler (ORCID: https://orcid.org/0000-0002-3399-9047)
- Parul Gupta (ORCID: https://orcid.org/0000-0001-9456-818X)
- Bradford E. Jackson (ORCID: https://orcid.org/0000-0003-0950-2907)
- Hanna K. Sanoff (ORCID: https://orcid.org/0000-0001-8679-4486)
- Michele Jönsson Funk
- Andrew M. Moon
- A. Sidney Barritt
- Jennifer L. Lund
Institutions
- University of North Carolina at Chapel Hill (US)
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- North Carolina Medical Journal
- Published
- 2025-12-23
- DOI
- https://doi.org/10.18043/001c.151714
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- Pfizer
- North Carolina Department of Health and Human Services
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill